Overview

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Status:
Completed

Trial end date:
2005-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate a therapy combining the established FUNIL regimen with Thalidomide. We want to see how well the therapy works, if it can be easily done, and how well the body handles the treatment. We also wish to see if the addition of Thalidomide will increase the effectiveness of the already established treatment regimen.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

New Mexico Cancer Care Alliance

Treatments:

Fluorouracil
Interferon-alpha
Interferons
Interleukin-2
Thalidomide